LRN: EPS Rose. Did the Business Improve?

The 60-second read

Five things to know

1. Revenue growth did not mean enrollment growth. Revenue rose 3.0%, while average enrollment fell 2.5%. Higher revenue per enrollment and Career Learning mix carried the top line.
2. A compensation credit changes the earnings story. GAAP operating profit rose 22.2%, but adjusted operating profit fell 3.1%. Reported stock-compensation expense was negative $7.4M; its specific cause is not established by the release.
3. The denominator matters. GAAP net income fell 5.6%, yet GAAP EPS rose 3.6% as diluted shares fell. Adjusted EPS uses a separate capped-call-adjusted denominator and fell 9.9%.
4. Cash improved without becoming positive. First-quarter operating cash used $124.8M. Receivables are seasonally high, and software investment plus finance-lease principal must still be funded.
5. The latest $38 target is not for this issuer. The provider linked a CHYM / Stride Bank article to LRN. We reject it and label genuine older $94 and $125 LRN targets as stale observations.

Three scenarios, one probability-weighted number

Analyst scenarios; USD per common share, not issuer guidance.

Signposts: what would change our mind

These are analytical thresholds, not management promises. $64 is 20% below the $80 base; a lower price is insufficient if the business deteriorates.

The tape

The saved valuation reference is $78.95, the October 20 regular-session close. That close predates the reported results. Its negative 2.5% regular-session move is not a post-earnings reaction. A later indicative bid of $76.00 and ask of $78.74 does not establish an executed price, and we do not substitute their midpoint into the valuation. The release date is verified, but its exact minute is unconfirmed. The scheduled call time is not a substitute for it.

Price history describes what owners have experienced; it does not establish intrinsic value. The saved 52-week range is $60.61–$155.06. A stock can fall substantially and still lack a margin of safety if earnings assumptions also deteriorate. Conversely, a weak quarter can coexist with a valuable business. Our $80 central estimate is deliberately close to the dated quote, so the decision depends more on operating evidence and price discipline than on a large claimed valuation gap.

The provider market capitalization of $3.281B uses a different share basis from our current GAAP diluted denominator. We preserve the observation but do not mix it into the per-share model. We use 44.828092M weighted diluted shares consistently. Quarter-end common shares are 42.031838M; adjusted diluted shares are 41.870086M after the issuer’s capped-call adjustment. These measures serve different purposes. Choosing the smallest denominator would increase apparent value without improving the business.

What the quarter says

The Q1 FY2027 earnings release reports revenue of $639.378M for the quarter ended September 30, up 3.0% from $620.884M. GAAP operating profit increased from $68.983M to $84.268M. GAAP net income nevertheless fell from $68.800M to $64.919M. Diluted EPS rose from $1.40 to $1.45 because the average diluted share count fell more quickly than net income. This is a legitimate per-share result, but it is not evidence that total recurring profit rose.

Adjusted results tell a more cautious story. Adjusted operating income declined from $81.138M to $78.646M, and adjusted net income declined from $71.986M to $57.259M. Adjusted EPS fell from $1.52 to $1.37 despite a smaller adjusted denominator. The release reconciles those measures explicitly. We show GAAP and adjusted views together rather than choosing whichever supports an optimistic or pessimistic headline.

FY2027 guidance is $2.53B–$2.61B revenue and $500M–$530M adjusted operating profit. The corresponding GAAP operating-profit range is $479.5M–$503.5M after stated compensation and amortization adjustments. Q2 guidance calls for $625M–$645M revenue and $135M–$145M adjusted operating profit. These prospective ranges are not reported cash receipts or proof that first-quarter weakness has already reversed.

Enrollment, mix and pricing

General Education revenue fell to $356.606M from $363.116M. Career Learning rose to $282.772M from $257.768M. Within Career Learning, middle- and high-school revenue increased to $272.098M from $241.500M, while adult revenue fell to $10.674M from $16.268M. A single Career Learning growth rate would conceal the adult decline, and a total-company growth rate would conceal weakness in General Education.

Average enrollment was 241.4K, down 2.5% from 247.7K. Career Learning enrollment was 112.2K, up 2.0% from 110.0K. Revenue per enrollment increased to $2,556 from $2,388; current General Education and Career Learning figures are $2,670 and $2,425. Adult programs are excluded from that calculation. We do not divide all reported revenue by the school enrollment count and present the result as the issuer’s exact KPI.

The favorable interpretation is that career-oriented programs are winning students and generating better revenue per student. The challenge is proving that this mix compensates for softer overall enrollment without weakening retention, service quality or collections. Higher revenue per enrollment can reflect funding and program mix as well as pricing. It is not automatically a discretionary price increase management can repeat indefinitely.

The release supplies revenue categories, but not separate operating profit for each category. We do not invent a Career Learning margin or assume adult programs are profitable or loss-making from revenue alone. Consolidated gross margin, mix and subsequent delivery-cost disclosures can be tested. This prevents attractive category growth from becoming an unsupported category-profit claim.

The earnings bridge

Instructional costs rose to $398.261M from $378.761M. Gross profit slipped from $242.123M to $241.117M despite higher revenue. Current gross margin is 37.7%. Selling, general and administrative expense fell by $16.291M, from $173.140M to $156.849M, producing the increase in GAAP operating profit. That expense movement deserves scrutiny because gross profit itself did not improve.

Stock-compensation expense changed from positive $10.222M to negative $7.392M. The $17.614M swing exceeds the $15.285M increase in GAAP operating profit. It is central to the headline. The release does not establish the specific reason for the credit, and the current quarterly note is not yet filed in the reviewed source set. We do not attribute it to a named executive’s departure or a particular award without that note.

The operating bridge is $84.268M GAAP profit plus $1.770M intangible amortization minus $7.392M compensation expense, producing $78.646M adjusted operating profit. A negative compensation expense becomes a subtraction in the adjustment. Reversing the sign would falsely inflate adjusted earnings. The net-income bridge also includes a negative $2.038M tax effect, taking $64.919M GAAP net income to $57.259M adjusted net income.

Net interest expense was $2.906M and other income $1.477M, versus $3.075M and $16.914M a year earlier. Pretax income was almost unchanged at $82.839M versus $82.822M. The tax provision increased to $17.840M from $14.423M, and the equity-method result changed from positive $0.401M to negative $0.080M. Lower other income and higher tax help explain why net income declined despite higher operating profit.

What belongs to each share

A smaller share count can improve each remaining owner’s claim, but it does not turn shrinking total profit into operating growth. GAAP diluted shares declined 8.9%, from 49.222851M to 44.828092M. Adjusted diluted shares declined 11.7%, from 47.419345M to 41.870086M. The adjusted calculation removes 2.958006M shares for the current capped-call effect, versus 1.803506M a year ago. These reductions are not open-market repurchases.

The accounting denominator differs again from 42.031838M common shares outstanding at quarter end, up from 41.477230M at June 30. Average-share measures reflect timing throughout a quarter; ending shares are a snapshot. Our model uses the more conservative GAAP diluted count consistently. We do not credit a separate capped-call windfall on top. Future conversion and settlement choices remain a source of uncertainty.

Receivables reached $854.808M from $664.788M at June 30. Ending receivables divided by quarter revenue times a 90-day convention gives a 120.3-day proxy. This is not average-balance DSO. The annual filing explicitly describes first-quarter receivables as seasonally high. The allowance was $31.751M versus $31.302M at June. Seasonality is not evidence of fictitious sales; unexplained aging, weaker collections or a rising loss allowance would be more informative.

Our quality judgment is mixed. Revenue grows, but enrollment and gross profit weaken. GAAP EPS rises, but adjusted earnings and total net income fall. Cash use improves, yet the quarter remains cash consuming. The company provides reconciliations that reveal these differences. The missing detail is why compensation expense is negative and how sustainable the underlying cost base is. Those questions should be tested against the next filed notes.

Cash, leases and capital allocation

Operating cash used $124.787M in Q1 versus $195.780M a year earlier. The $70.993M improvement is substantial, but the result remains negative. Receivable cash use improved by $61.132M, from $253.026M to $191.894M. That explains much of the change. It does not mean the improvement came entirely from recurring margin expansion, and a seasonal first-quarter outflow should not be annualized as the expected full-year result.

Cash investment includes $17.911M software, $6.567M curriculum and $0.004M property purchases. Conventional free cash flow, defined as operating cash less these investments, was negative $149.269M. Subtracting $16.540M finance-lease principal gives negative $165.809M. We show both definitions because leased equipment is a genuine cash obligation even when principal appears in financing rather than investing cash flow.

The three-year record provides a seasonal anchor. FY2026 operating cash was $433.814M and conventional FCF $354.968M. After $56.856M lease principal, $298.112M remained. Deducting $40.255M stock compensation as an economic owner-cost proxy gives $257.857M. That last measure is an analytical proxy, not a GAAP line or our enterprise model’s starting cash flow. It resists treating every noncash add-back as free to owners.

The provider classified the $56.856M lease repayment as positive net debt issuance. The primary statement identifies a repayment, so the provider sign and category are rejected. It also classified FY2025 and FY2024 restricted-stock tax withholding of $21.469M and $8.200M as common-stock repurchases. Primary treasury purchases are zero in both years. Withholding settles employee tax obligations; it should not be advertised as discretionary capital return.

September cash was $547.750M and current securities $241.425M, totaling $789.175M. The release’s $884.2M cash-and-marketables total includes noncurrent investments. The roughly $95.0M difference comes from a rounded total, not a separately identified new cash line. Our conservative model credits current liquid assets and deducts $420M convertible principal, leaving $369.175M. Lease principal is modeled as reinvestment rather than also deducted as debt.

The 1.125% notes mature September 1, 2027, in FY2028. Current carrying value is $418.431M, but principal is $420M. Settlement is cash up to principal; the conversion spread can be cash or shares at company election. The conversion price is $52.88 and capped-call upper strike $86.174. The old $60.4M capped-call premium is not fresh cash. A funded settlement plan matters more than calling these instruments cheap financing in isolation.

What the dated price requires

Our central value is $80, with a $55–$110 scenario range and $81.25 weighted value. Against $78.95, central upside is only 1.3%. That is insufficient for a strong purchase recommendation given the operating and accounting uncertainty. HOLD with conviction 3/5 means the business has plausible cash-generating value, but price does not compensate us for enough things going wrong. The $64 entry reference is a 20% discount to the base, conditional on intact facts.

The enterprise operating-cash route assumes FY2027 GAAP EBIT of $490M, cash tax of 25%, depreciation and amortization of $130M, cash capex of $75M, lease principal of $60M and working-capital investment of $67.5M. Cash flow is $295M: 490 times 75%, plus 130, minus 75, minus 60, minus 67.5. These are analyst assumptions. Some sit near guidance, but management did not issue this cash-flow forecast.

Stock compensation remains an expense in starting GAAP EBIT; we do not add it back. Depreciation is added back, cash lease principal is deducted as equipment reinvestment, and lease debt is not subtracted again in the equity bridge. Cash capex and lease principal are separate. This avoids both omitting recurring equipment cost and deducting debt twice. Noncurrent securities are excluded rather than assumed immediately spendable.

Five annual cash flows are $295M, $310M, $325M, $340M and $355M for FY2027–FY2031. At 12% discount and 2% terminal growth, their present value is $1,159.364M. Terminal value contributes another $2,054.653M in present value. Adding $369.175M net cash and dividing by 44.828092M shares yields $79.93. The large terminal contribution makes long-run economics and required return material assumptions, not finishing details.

The second route values $490M normalized GAAP EBIT at 6.5 times, adds the same net cash and divides by the same shares, producing $79.28. The third uses $325M normalized net income, or $7.25 per diluted share, at 11 times earnings to produce $79.75. No cash is added to the P/E result because it is already equity value. The multiples reflect execution, funding and enrollment risk; they are judgments, not observed peer medians.

The reverse calculation asks what constant annual cash growth reconciles the dated $78.95 close with the same $295M starting cash flow, discount rate, terminal growth, net cash and shares. The answer is approximately 4.32% across the four growth steps from FY2027 to FY2031. This constant-growth path differs from the nonuniform forward DCF. It is not EPS growth, enrollment growth or issuer guidance. A modest implied growth rate still depends on a credible starting cash flow.

The bear case uses $275M normalized net income at 9 times earnings for about $55. The bull uses $380M at 13 times for about $110, both with the same diluted shares. These are conditional outcomes, not confidence intervals or loss boundaries. The 25%, 50%, 25% weights produce $81.25. Correlated routes and subjective probabilities are not three independent confirmations of a certain future price.

Street evidence and its limits

The latest provider target is unusable for LRN. Its September 9 article explicitly concerns Chime Financial, ticker CHYM, acquiring Stride Bank, with a BMO target of $38. Stride Bank is not the listed education company. The provider attached this article to LRN and returned a $38 aggregate target. We preserve the body and reject both the observation and the contaminated aggregate. A convenient consensus field does not override issuer identity.

Genuine LRN-named records from January 28, 2026 show BMO at $94 and Canaccord at $125. They are stale observations, not confirmed responses to October results. We neither average them into a current consensus nor claim reaffirmation. The saved ratings distribution says Hold: 5 buys, 10 holds and 2 sells across 17 analysts. Its post-release update status is unverified. Our HOLD is broadly consistent with that label, while any dollar-target comparison remains qualified.

The forecast set has three revenue analysts and two EPS analysts for FY2027: revenue $2,540.725M and EPS about $7.42. FY2028 revenue is $2,643.925M and EPS about $7.93; later-year coverage narrows further. These are dated vendor expectations, not issuer guidance or proof of a surprise against a clean pre-release consensus. Our valuation uses explicit assumptions rather than silently importing these forecasts.

Governance and capital choices

The October 8 Fivespan cooperation agreement is a governance and capital-allocation development. Its filing describes board appointments, a capital-allocation committee and withdrawal of a proxy proposal. It is not a pending acquisition of the listed parent and does not prevent analysis of the common stock. Its relevance is whether capital discipline, execution and disclosure improve. An agreement alone does not establish that these improvements have occurred.

The $500M repurchase authorization began in November 2025 and runs through October 31, 2026. FY2026 program purchases were $188.659M at an average $81.50, leaving $311.3M at June 30. Authorization is capacity, not a promise to spend. Convertible maturity and seasonal working capital matter before assuming buybacks are the best use of every dollar. Employee-award withholding remains separate from discretionary purchases.

Stride reports 9,200 employees in FY2026, versus 8,600 and 7,800 in the prior years. Delivery capacity and instructional quality matter alongside efficiency. Current auditor KPMG succeeded BDO, which audited the FY2024 comparative. No single contract exceeded 10% of revenue in the three-year period, but dependence on public education funding remains important. Contract diversification does not eliminate common policy or funding shocks.

No prior LRN episode was found in compact canonical records. This is an initial call, not an invented upgrade or downgrade. The forbidden shortcut is equating revenue growth with enrollment growth, or GAAP EPS improvement with stronger adjusted earnings. Later updates should retain the same cash definitions, share bases and dated assumptions, so the assessment changes because evidence changed rather than because an inconvenient metric disappeared.

Risks and counterarguments

The highest operational risk is persistent enrollment decline masked by higher revenue per student. Public funding, school authorization, academic outcomes and retention can affect economics together. Instructional delivery and technology execution are essential. A lower administrative-cost line is not a success if outcomes or retention weaken. Career Learning is the strongest offset, but its separate profit contribution is not disclosed.

Cash and capital are the second concern. Seasonal receivables still require collection. Software and curriculum need reinvestment, equipment leases require principal payments, and $420M of convertible principal falls due in September 2027. Current liquidity provides flexibility. It does not eliminate operating needs or justify counting the same cash as shareholder surplus and as money reserved to settle debt.

Measurement is another risk. The compensation credit lacks an established explanation; capped-call-adjusted EPS differs from GAAP; the latest target is misclassified; and later forecasts have thin coverage. These facts demand evidence and a discount, not fabricated precision. Our 12% discount rate and modest multiples reflect uncertainty, but another investor can reasonably choose a different required return.

The historical platform securities case should not be labeled unresolved. The FY2026 annual report states that all claims against the company and individual defendants were dismissed on June 18, 2026. Allegations concerned legacy technology and a new platform rollout; allegations are not established findings. Technology remains operationally important, while the disclosed case status is resolved. No later primary reversal was identified in this source set.

The strongest bullish case is that Career Learning, improved collections and fewer shares can produce attractive owner returns without rapid overall enrollment growth. The model does not require heroic growth after its initial $295M cash assumption. The bearish response is that the starting cash flow and stable funding are precisely what need proof. HOLD balances those cases: the enterprise has value, but a quote near the base offers limited protection.

What would change the call

The next quarterly filing should explain the compensation credit and relevant award and tax details. This is an information gap, not a basis for inventing misconduct or a filing-delay exclusion. We want a consistent cost comparison and evidence that expense reductions are sustainable. A legitimate accounting reversal can still be a weak foundation for extrapolating recurring earnings.

Q2 tests the $135M–$145M adjusted operating-profit guide and whether enrollment stabilizes. We would look for maintained annual revenue guidance, clearer Career Learning economics and normal seasonal collections. Our full-year operating-cash green threshold is $400M and red threshold $350M. These analytical tests are not issuer promises. Investment, taxes and timing need explanation before one threshold determines the call.

Capital decisions matter before the authorization expires October 31, 2026 and notes mature September 1, 2027. An extension, financing or settlement plan should be judged by cost and each continuing share’s economics. A larger authorization is not a realized return. Conversion is not automatically equivalent to full principal dilution. Actual settlement terms and durable per-share cash are what matter.

At or below $64 with the case intact, the discount to our $80 base becomes more interesting. At a higher price, stronger and better-supported cash generation is needed. If enrollment, collections or capital discipline deteriorate, base value must change rather than remain fixed. The next update should explain both the changed fact and its effect on value.

1. What caused the compensation credit, and what recurring expense remains?
2. Can Career Learning grow without concealing weakness elsewhere?
3. Do receivables convert on the normal seasonal schedule?
4. How will convertible principal be funded without sacrificing owner value?
5. Does the next Street revision concern this issuer and these results?

Sources and methods

The dataset retains nine primary quarterly exhibits, three annual filings, recent quarterly filings, SEC company facts, current governance evidence and authenticated market responses. Complete P&L, balance-sheet and reconciliation tables remain available. Missing category operating profit is explicitly unavailable, not estimated from revenue shares. Amounts are USD unless stated; raw tables retain original thousands and share-count units.

Derived figures are calculated from saved data. Growth compares the same fiscal quarter. FCF deducts software, curriculum and property purchases; lease-adjusted cash also deducts financing principal. The owner-cost proxy additionally deducts compensation but is not substituted for enterprise DCF. Receivable days use ending balances and a disclosed 90-day convention, not average DSO. These definitions prevent false comparisons.

Primary filings define results, classifications and contracts. Market data provides dated prices and forecasts. Analyst judgment supplies valuation assumptions and probabilities. The false $38 target remains rejected evidence. Release minute and post-release analyst revisions remain unconfirmed. Neither filing timestamps nor call schedules silently become release times. The source and model records preserve what was known for later reassessment.